310 related articles for article (PubMed ID: 28303323)
1. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
[No Abstract] [Full Text] [Related]
2. Transthyretin amyloidosis in a septuagenarian masquerading as hypertrophic cardiomyopathy: the importance of multimodality imaging.
Chawla D; Cheema O; Jan MF; Tajik AJ
Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):328. PubMed ID: 29272373
[No Abstract] [Full Text] [Related]
3. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
4. Acute cardiac failure secondary to senile systemic amyloidosis.
Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man.
Marrero Negrín N; Medina Gil JM; García Cruz ML; Jiménez Cabrera F
Rev Esp Cardiol (Engl Ed); 2019 Dec; 72(12):1086-1088. PubMed ID: 31561982
[No Abstract] [Full Text] [Related]
6. Cardiac amyloidosis with gastrointestinal involvement: a case report.
Tantau A; Avram I; Cozma A; Sampelean D
Med Ultrason; 2015 Mar; 17(1):123-5. PubMed ID: 25745667
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Involvement Secondary to a Familial Form of Transthyretin Amyloidosis Resulting From the Glu54Gln Mutation.
Torres-Courchoud I; Martínez-Gil R; Aibar-Arregui MA; Andrés-Gracia A; Torralba-Cabeza MA
Rev Esp Cardiol (Engl Ed); 2017 Apr; 70(4):297-299. PubMed ID: 27519456
[No Abstract] [Full Text] [Related]
8. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy.
Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S
AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870
[TBL] [Abstract][Full Text] [Related]
9. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
10. Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.
Shintani Y; Okada A; Morita Y; Hamatani Y; Amano M; Takahama H; Amaki M; Hasegawa T; Ohta-Ogo K; Kanzaki H; Ishibashi-Ueda H; Yasuda S; Shimazaki C; Yoshinaga T; Yazaki M; Sekijima Y; Izumi C
ESC Heart Fail; 2019 Feb; 6(1):232-236. PubMed ID: 30478886
[TBL] [Abstract][Full Text] [Related]
11. Multimodality imaging of cardiac amyloidosis.
Benz DC; Dorbala S
Heart; 2024 May; 110(12):873-882. PubMed ID: 37586824
[No Abstract] [Full Text] [Related]
12. Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment.
Wu YA; Tsai CH; Su MY; Chao CC; Cheng MF; Shun CT; Hsieh ST; Lin YH
ESC Heart Fail; 2022 Dec; 9(6):4335-4339. PubMed ID: 36128649
[TBL] [Abstract][Full Text] [Related]
13. Cardiac sarcoidosis diagnosed by multimodality imaging.
Fujikura K; Garcia MJ
Echocardiography; 2017 Sep; 34(9):1374-1375. PubMed ID: 28752531
[TBL] [Abstract][Full Text] [Related]
14. Early identification of transthyretin-related hereditary cardiac amyloidosis.
Arbustini E; Merlini G
JACC Cardiovasc Imaging; 2014 May; 7(5):511-4. PubMed ID: 24831211
[No Abstract] [Full Text] [Related]
15. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Varedi D; Kovacsovics T; Downs Kelly E; Abraham J; Cowley J; Barrell K; Revelo MP; Stehlik J; Drakos S; Marrouche N; Wilson B; Swanson EA; Fang J; Nativi-Nicolau J
Circ Heart Fail; 2018 Jul; 11(7):e004812. PubMed ID: 29921704
[No Abstract] [Full Text] [Related]
16. Transthyretin Cardiac Amyloidosis Disguised as Light Chain Amyloidosis or Multiple Myeloma?
Stein AP; Matthia EL; Petty SA; Stewart B; Vilaro JR; Al-Ani MAZ; Ahmed MM; Aranda JM; Hiemenz JW; Parker AM
Am J Cardiol; 2024 Jan; 210():85-92. PubMed ID: 37852567
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
[TBL] [Abstract][Full Text] [Related]
18. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
[TBL] [Abstract][Full Text] [Related]
19. [Ten questions about transthyretin amyloidosis].
Giovannetti A; Accietto A; Massa P; Leone O; Guaraldi P; Saturi G; Caponetti AG; Sguazzotti M; Ponziani A; Gagliardi C; Galiè N; Cortelli P; Longhi S; Biagini E
G Ital Cardiol (Rome); 2022 Sep; 23(9):676-685. PubMed ID: 36039718
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
González-López E; López-Sainz Á; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
